Workers’ Compensation Executive Will Focus on Rapid Adoption of Innovative Vx Therapy to Heal Trauma
LAS VEGAS–(BUSINESS WIRE)–#AI–Harvard MedTech today announced that senior sales and business development executive Mark Moore is joining the company as Senior Vice President, Market Partnerships.
Harvard MedTech is a breakthrough digital health company that combines virtual reality, behavioral therapy, and artificial intelligence in a revolutionary new approach to healing trauma and pain.
“As we continue to expand our footprint in the workers’ compensation industry, Mark’s experience will be critical for our growth,” said Pat McCutcheon, Chief Sales Officer, Harvard MedTech. “Mark will be an invaluable member of our team, bringing a focus on developing strategies and execution with all stakeholders that align with the best outcomes.”
“Harvard MedTech is truly a game-changer in the workers’ compensation space,” said Moore. “Harvard MedTech’s Vx Therapy is the ideal solution for treating pain and trauma without drugs or surgical interventions, in the patient’s home, using a cost-effective digital delivery system. I am excited to be part of a team dedicated to improving the recovery for injured workers that also provides payers with the opportunity for reduced risk and costs.”
The workers’ compensation sector has long struggled to find solutions to alleviate chronic pain and trauma, resolve behavioral health issues related to injuries, and find alternatives to treat pain without potentially addictive drugs, expensive surgeries, or long-term therapy. Harvard MedTech’s Vx Therapy solution treats all aspects of trauma by retraining neural pathways and changing the way the brain interprets and processes emotions and physical pain. Patients learn to lessen the experience of pain, become more resilient, recover faster and re-engage with their lives and work.
Moore comes to Harvard MedTech with 16 years of consultative sales and leadership experience, 10 of which were spent in workers’ compensation collaborating with insurance, carriers, TPAs, and employers to introduce and drive solutions with meaningful clinical and cost containment value. At Harvard MedTech, he will report directly to Pat McCutcheon and be responsible for overseeing the interface of customer relations and business development throughout the U.S.
For more information, visit www.Harvardmedtech.com.
About Harvard MedTech
Harvard MedTech is a breakthrough digital health company that is tapping the new science of how the brain works, combining specially designed virtual reality experiences, psychosocial support, digital engagement and proprietary AI algorithms to retrain neural pathways and alleviate the effects of trauma, including pain, PTSD, anxiety, depression and sleep disorders. The company’s Vx Therapy model is the first to comprehensively integrate this unique combination of digital technologies with behavioral health interventions, in a virtual application that moves the points of care to the patient’s home. This virtual engagement drives high compliance, patient satisfaction and optimal outcomes. It also allows the solution to be affordable and scalable at a population health level. This non-invasive and non-pharmacological approach also provides data that is trackable for a clear assess of its value to patient and health care providers. Visit www.harvardmedtech.com for more information.